MAL and ovarian carcinoma: It is interesting to note that, although MAL is hypomethylated and is normally expressed in OV and ovarian cancer cell lines, its expression is upregulated in response to treatment of ovarian cancer cell lines with 5-aza-2′-deoxycytidine, indicating that the methylated region at the promoter region regulates MAL expression [130].